SAVA HEALTHCARE Receives Minzdrav Rossii (Russia) GMP Approval for its Dry Powder Inhalation (DPI) Capsule Manufacturing Unit Based at Surendranagar, India

News provided by

SAVA Healthcare Limited.

22 May, 2018, 15:34 BST

PUNE, India, May 22, 2018 /PRNewswire/ --

SAVA HEALTHCARE LIMITED which specializes in manufacture and marketing of Nasal Sprays and Dry Powder Inhalers (DPI) announced that the Russian Ministry of Health (MOH) Minzdrav Rossii has approved its DRY POWDER INHALER (DPI) capsules manufacturing line for Respiratory Therapeutic segment. This will strengthen SAVA's presence in the Russian and CIS region.

SAVA's Surendranagar facility is also accredited by HEALTH CANADA, PICs Ukraine, WHO-GMP, amongst other Drug Administration authorities.

SAVA has developed latest generations DPIs like Tiotropium, Formeterol, salmeterol/fluticasone, Budesonide/Formeterol Fumarate for Russian and other CIS markets.

DSIR approved in-house R&D Center of SAVA at Pune (India) is well-equipped Formulations R&D centre catering to Dry Powder Inhalers (DPI) development and has best in class R&D equipments like Dosage Unit Sampling apparatus (DUSA), Next Gen Impactor (NGI) and Glass Twin Impinger (T1, T2).

Commenting on this development Mr.Vinod Ramchandra Jadhav, Chairman of SAVA Group said, "This endorsement of SAVA commitment to meeting GMP guidelines is welcoming news and gives SAVA access to RUSSIAN pharmaceutical market which is estimated at 22 billion USD growing by 10% out of which respiratory drug category stands on 2nd fastest growing segment."

About SAVA HEALTHCARE
SAVA HEALTHCARE Limited is Health Canada accredited, PIC/S approved, WHO GMP Manufacturer based in Surendranagar India. Its Herbal extraction unit in Bangalore is inspected by USFDA.

SAVA HEALTHCARE LIMITED internationally is present in 35+ countries with more than 300 + product registrations. SAVA specialises in Dry Powder inhalers (DPI), Nasal Sprays, Tablets and Capsules, Dermatology, Veterinary Products, and USDA approved Herbal Extracts.

SAVAVET is SHL's Small Animal veterinary Division focusing on Indian market and ranked amongst top 5 veterinary prescription drug companies of India.


Organisation: SAVA HEALTHCARE LTD
Name: Mr. Naresh Katara, CEO
Email: sales@savaglobal.com
Corporate office: Sava House, Viman Nagar Pune 411014, India
Phone: +91-203-051-6100, WEB: http://www.savaglobal.com